In this episode, Mélanie Pomerleau, Vice President of Quality and Compliance at Indero, joins us to explore the upcoming ICH E6 (R3) guideline revision. With over 25 years in the pharmaceutical and biotech industries, Mélanie shares expert insights on key changes, including the restructured document format, modernized GCP principles, enhanced patient centricity, and the integration of decentralized and adaptive trial designs. We also discuss evolving regulatory expectations, audit trends, and the growing importance of data governance. Tune in to understand how sponsors, CROs, and sites can prepare for the July 2025 implementation and navigate this transition. 

Episode 28: What is New With ICH E6 (R3)?

Phase Forward: Your Gateway to Dermatology and Rheumatology Clinical Research
Dive into the world of dermatology and rheumatology clinical research with Phase Forward, the podcast that brings you the latest insights, innovations, and expert advice. Powered by Indero, a leading full-service CRO, this podcast is your go-to source for everything you need to know about managing and conducting clinical trials in these fields.
Each episode features engaging interviews, thought-provoking discussions, and captivating stories from the forefront of clinical research. Whether you are a sponsor, investigator, or study coordinator, you will find valuable information and practical tips to enhance your work.
Stay ahead of the curve with updates on the newest advancements in trial design and methodology, and gain a deeper understanding of the processes and considerations in clinical research.
Don't miss out—subscribe now and join the conversation on dermatology and rheumatology clinical research with Phase Forward!

New tracks tagged #Inspection and Audit Trends with R3